HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Krishna Selected Research

G Krishna Research Topics

Disease

4Invasive Fungal Infections
02/2010 - 02/2006
1Chronic Hepatitis C
12/2013
1Mycoses (Diseases, Fungus)
11/2012
1Diarrhea
02/2010
1Mucositis
02/2010
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
02/2010
1Vomiting
02/2010
1Neutropenia
02/2010
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2010
1Dizziness (Lightheadedness)
06/2009
1Headache (Headaches)
06/2009
1Febrile Neutropenia
02/2006
1Breast Neoplasms (Breast Cancer)
03/2002
1Neoplasm Metastasis (Metastasis)
03/2002
1Carcinoma (Carcinomatosis)
03/2002
1Hypercholesterolemia
06/2001
1Infections
03/2001
1Idiopathic Pulmonary Fibrosis
03/2001
1Fibrosis (Cirrhosis)
03/2001
1Parkinsonian Disorders (Parkinsonism)
01/2000
1Craniocerebral Trauma (Head Injury)
01/2000
1Dementia (Dementias)
01/2000
1Parkinson Disease (Parkinson's Disease)
01/2000
1Retrograde Degeneration
01/2000

Drug/Important Bio-Agent (IBA)

5posaconazoleFDA Link
11/2012 - 02/2006
2Antifungal AgentsIBA
06/2009 - 03/2007
2TriazolesIBA
06/2009 - 03/2007
1Ribavirin (Virazole)FDA LinkGeneric
12/2013
1peginterferon alfa-2b (Pegintron)FDA Link
12/2013
1TabletsIBA
11/2012
1Proton Pump InhibitorsIBA
02/2010
1TransferasesIBA
02/2010
1BilirubinIBA
02/2010
1SuspensionsIBA
02/2006
1CholesterolIBA
06/2001
1Ezetimibe (Zetia)FDA Link
06/2001
1Pharmaceutical PreparationsIBA
03/2001
1evernimicinIBA
03/2001
1Bleomycin (Blenoxane)FDA LinkGeneric
03/2001
1omtriptolideIBA
03/2001
1triptolideIBA
03/2001
1Dopamine (Intropin)FDA LinkGeneric
01/2000
1hydroxide ionIBA
01/2000
1AntioxidantsIBA
01/2000
1Free RadicalsIBA
01/2000
1neuromelaninIBA
01/2000
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2000
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2000
1Hydroxyl RadicalIBA
01/2000
1IronIBA
01/2000
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2000
1Proteins (Proteins, Gene)FDA Link
01/2000

Therapy/Procedure

1Drug Therapy (Chemotherapy)
02/2010
1Aftercare (After-Treatment)
03/2002